At a glance
ClinicalIndex Comparison RecordN/ACompleted· 197 enrolled
Drug / intervention
Pacing Leaddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Model 4396 Left Ventricular Lead Study
In Brief
A clinical study evaluating Pacing Lead for Heart Failure. Completed, enrolled 197 participants across 31 sites in 8 countries.
Detailed Summary
This study is designed to show that a new lead, which paces the left bottom chamber (left ventricle) of the heart, is safe and effective. Using a lead on the left side of the heart has been shown to potentially improve heart failure symptoms. The shape and size of this new lead may make it a good choice for patients or physicians.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesAustralia, Austria, Canada, Denmark, France, Italy, Saudi Arabia, United States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedMar 2009
Primary CompletionJul 2009
Study CompletionAug 2010
TodayJul 2026
First PostedMar 2, 2009
Enrollment StartMar 1, 2009
Primary CompletionJul 1, 2009
Study CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.3 years ago
Interventions
Pacing Leaddevice
implant and follow-up of study device